Jump to content

Covid-19 News/Discussion


bucsfan333

Recommended Posts

Supplementals:

 

Molnupiravir, a pill that could be taken at home, had shown promise in cutting the risk of hospitalization and death by half among high-risk patients in data released by the company in October. But according to the latest findings Merck presented to the FDA, the pill reduced the risk of hospitalization and death only by 30 percent.

The study by the drugmakers found that, among participants receiving the pill, just one participant died during the trial, compared with nine deaths in the placebo group, the companies said in a news release Friday.

 

Free: What to know about the omicron variant of the coronavirus.

https://www.washingtonpost.com/health/2021/11/26/faq-new-variant-omicron/

Link to comment
Share on other sites

19 hours ago, DontTazeMeBro said:

We’re living in it. I don’t know why the trials had the results that they did. But 90% would make break through cases a rare occurrence. And they’re happening all the time. Even by the theory that enough people aren’t vaccinated. Israel is heavily vaccinated and shouldn’t still be having the problems they are. Why is this even controversial? Everyone should want a vaccine that’s as effective as possible.

Because antibodies wane, which happens with damn near every vaccine and virus induced infection. Once antibodies wane- we can become infected, but our memory cells will hold the fort down turning a severe disease into that of an illness ranging from sinus irritations to that of a mild flu (if symptomatic at all). Boosters restore the antibodies, which in return diminishes the chance of infection.

Edited by WizeGuy
  • Like 3
Link to comment
Share on other sites

1 hour ago, Deadpulse said:

gonna wait for a few more big D's to back this claim up

Apparently she was referring to vaccinated people:

https://twitter.com/sailorrooscout/status/1464660667546411011?t=fKOCbocyh3JpjLeMz2gI3g&s=19

 

Then there's this:

https://www.telegraph.co.uk/global-health/science-and-disease/south-african-doctor-raised-alarm-omicron-variant-says-symptoms/

It's all anecdotal at this point,  though. 

Edited by WizeGuy
  • Like 2
Link to comment
Share on other sites

Quote

More than 85% of all intensive care unit (ICU) beds and 85% of all hospital inpatient beds in Michigan are currently full, a dangerous and potentially deadly level of overcrowding as the state’s health system is strained by a fourth surge of COVID-19 cases.

At least eight hospitals are 100% full, according to the latest state data. West Michigan’s largest hospital system, Spectrum Health, has reached a system-record number of patients in both its hospitals and its ICUs.

Source

Hope you all enjoyed your Thanksgiving and shopping weekend.

Link to comment
Share on other sites

Omicron Tracker

Popping up more and more places now, including Canada. Safe to wager it's in the US by now. Hopefully it ends up not being a big deal. But one report stated: "Young people, in their 20s to just over their late 30s, are coming in with moderate to severe disease, some needing intensive care. About 65% are not vaccinated and most of the rest are only half-vaccinated.".

Everything I see on social media is showing indoor bars and concerts packed again with no masks or social distancing. Could be a long winter.

 

Edit: Only ~60% of that age group is vaccinated in the US according to here.

Edited by kingseanjohn
Link to comment
Share on other sites

Vaccine makers are rushing to explore ways to tailor their coronavirus shots to combat the newly-identified omicron variant that is prompting countries around the world to tighten restrictions in an effort to stop the spread.

U.S. firm Moderna has mobilized hundreds of people as it anticipates its existing vaccine could lose some efficiency against omicron though it would still provide a level of protection, and a new version could be available by next year if needed, executives said.

Germany’s BioNTech said in a statement Monday that development had started to move as quickly as possible while scientists simultaneously research the need for a new shot, Bloomberg reported, and Pfizer CEO Albert Bourla told CNBC a new template was made to develop a vaccine for the variant. Moderna — which said Friday it would advance an omicron-specific booster candidate — “should know about the ability of the current vaccine to provide protection in the next couple of weeks,” according to its chief medical officer Paul Burton, speaking Sunday on the BBC. “We’ve mobilized hundreds of people,” he said. “If we have to make a brand new vaccine, I think that’s going to be early 2022 before that’s really going to be available in large quantities.”

Link to comment
Share on other sites

The European Union’s public health body on Tuesday reported 44 omicron variant coronavirus cases in 10 countries across the region.

Andrea Ammon, who chairs the European Center for Disease Prevention and Control, said during an online conference that the confirmed cases were all mild or without symptoms. Cases have been confirmed in Austria, Germany, Portugal, and the Netherlands, among other nations in Europe, the health body said.

Separately on Tuesday, Emer Cooke, executive director of the European Medicines Agency said Europe was ready to deal with the new variant, according to the Associated Press, and that it will take two weeks to assess whether the current vaccines work against it.

  • Like 1
Link to comment
Share on other sites

Some good news if you’re vaccinated or have a booster.

https://m.jpost.com/health-and-wellness/coronavirus/covid-1st-data-about-vaccine-efficacy-against-omicron-expected-tuesday-687392
 

Quote

There are indications that individuals fully vaccinated against corona within six months or with the booster are also protected against the Omicron variant, Health Minister Nitzan Horowitz said on Tuesday, after another two cases were identified, bringing the total to four.


 

Quote

Later in the evening, a report by Channel 12 said the Pfizer vaccine is just slightly less effective in preventing infection with Omicron than with Delta – 90% as opposed to 95% – while it is as effective – around 93% – in preventing serious symptoms at least for those vaccinated with a booster.


Some bad news:

Quote

According to the report, the ability of the variant to infect is higher than Delta but not as much as feared – around 1.3 times higher.

At the same time, those not inoculated have a 2.4 times greater chance of developing serious symptoms, a significant figure.

 

  • Like 3
Link to comment
Share on other sites

Guest
This topic is now closed to further replies.
×
×
  • Create New...